{
    "clinical_study": {
        "@rank": "127759", 
        "acronym": "MUCO SOPHRO", 
        "arm_group": {
            "arm_group_label": "sophrology sessions", 
            "arm_group_type": "Experimental", 
            "description": "The sophrology is a dynamic method of physical and psychical relaxation"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate the impact of the global approach to the pain in\n      cystic fibrosis patients with chronic or intermittent pain. The patients will receive in\n      addition to an usual pharmacological and psychological management, sophrology sessions at\n      home. The results of this study will provide a new strategy of management of the patient's\n      pain."
        }, 
        "brief_title": "Impact of Global Care of the Pain at Chronic Painful Patients Affected by Cystic Fibrosis", 
        "completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Cystic Fibrosis", 
        "condition_browse": {
            "mesh_term": [
                "Cystic Fibrosis", 
                "Fibrosis"
            ]
        }, 
        "detailed_description": {
            "textblock": "The majority of cystic fibrosis patients have chronic or intermittent pains. These pains\n      have important consequences on the quality of life. Currently, the treatment is essentially\n      pharmacological (essentially paracetamol) but it is not enough in presence of of visual\n      analogue scale (VAS) >4. In the study, the patients will receive in addition to an usual\n      pharmacological and psychological management, sophrology sessions at home. The sophrology is\n      a dynamic method of physical and psychical relaxation. This aims are to decrease the pain,\n      to decrease the anxiety and to improve the everyday life. This study will provide a new\n      global strategy of the management of the patients' pain."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Cystic fibrosis patients defined by a test sweat and / or 2 pathogenic mutations\n\n          -  Patients over 10 years\n\n          -  Patients with pain symptoms (VAS> 4) recurrent (> 4 episodes / month) or permanent\n             since more than 6 months\n\n          -  Agreement of patients, and parents (for children) for sophrology sessions conducted\n             at home.\n\n          -  Patient affiliated to social security\n\n        Exclusion Criteria:\n\n          -  Transplant patients or placed on a waiting list transplantation\n\n          -  Patients had a patient-support by techniques hypnosis or relaxation therapy, during\n             or within 3 months.\n\n          -  Patients enrolled in another research interventional protocol.\n\n          -  Women without contraception or pregnant."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "10 Years"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 20, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01915875", 
            "org_study_id": "P070706", 
            "secondary_id": "2008-A01575-50"
        }, 
        "intervention": {
            "arm_group_label": "sophrology sessions", 
            "description": "The sophrology is a dynamic method of physical and psychical relaxation", 
            "intervention_name": "sophrology sessions at home", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Cystic fibrosis-pain-sophrology", 
        "lastchanged_date": "August 2, 2013", 
        "location": {
            "contact": {
                "email": "Isabelle.sermet@nck.aphp.fr", 
                "last_name": "Isabelle Sermet, MD PhD", 
                "phone": "1 44 49 48 87", 
                "phone_ext": "+33"
            }, 
            "contact_backup": {
                "email": "laurence.lecomte@nck.aphp.fr", 
                "last_name": "Laurence Lecomte, PhD", 
                "phone": "1 71 19 64 94", 
                "phone_ext": "+33"
            }, 
            "facility": {
                "address": {
                    "city": "Paris", 
                    "country": "France", 
                    "zip": "75015"
                }, 
                "name": "h\u00f4pital Necker Enfants malades"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "1", 
        "official_title": "Impact of Global Care of the Pain at Chronic Painful Patients Affected by Cystic Fibrosis", 
        "overall_contact": {
            "email": "Isabelle.sermet@nck.aphp.fr", 
            "last_name": "Isabelle SERMET, MD PhD", 
            "phone": "1 44 49 48 87", 
            "phone_ext": "+33"
        }, 
        "overall_contact_backup": {
            "email": "laurence.lecomte@nck.aphp.fr", 
            "last_name": "Laurence Lecomte, PhD", 
            "phone": "1 71 19 64 94", 
            "phone_ext": "+33"
        }, 
        "overall_official": {
            "affiliation": "AP-HP", 
            "last_name": "Isabelle Sermet, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Change of maximum VAS for the site presenting a max VAS in the month following the inclusion.", 
            "measure": "Change of maximum VAS", 
            "safety_issue": "No", 
            "time_frame": "6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01915875"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Change of the number of paroxystic episodes", 
                "measure": "number of paroxystic episodes", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "description": "Change of the intensity of maximum VAS of the painful episodes between the month following the inclusion and last month of the study (for all the sites)", 
                "measure": "intensity of maximum VAS of the painful episodes", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "description": "Questionnaire of Quality of life CFQ 14 + and CHILD: physical functioning, vitality, body image  and respiratory symptoms", 
                "measure": "Improvement of the quality of life", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "description": "improvement of the BMI,", 
                "measure": "BMI", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "description": "improvement of the VEMS", 
                "measure": "VEMS", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "description": "improvement of the CVF", 
                "measure": "CVF", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "description": "improvement of the SaO2", 
                "measure": "SaO2", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }
        ], 
        "source": "Assistance Publique - H\u00f4pitaux de Paris", 
        "sponsors": {
            "collaborator": {
                "agency": "Fondation de France", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Assistance Publique - H\u00f4pitaux de Paris", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2012", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "August 2013"
    }
}